Immunotherapy improves prognosis for women with recurrent ovarian cancer in clinical trial
Results from a clinical trial show that a new immunotherapy treatment, when added to standard…
Browsing: ovarian cancer
Ovarian cancer drug niraparib maintains remission and extends time without symptoms
Findings from a recent clinical trial presented today at the Society of Gynecologic Oncology’s 50th…
Surge Protector: Novel approach to suppressing therapy-induced tumour growth
In a recent groundbreaking study, a team of researchers led by BIDMC’s Dipak Panigrahy, MD,…
Antihypertension drug losartan may improve treatment of ovarian cancer
A new study from a Massachusetts General Hospital (MGH) research team has found that the…
New blood test detects early stage ovarian cancer
Research on a bacterial toxin first discovered in Adelaide has led to the development a…
Diagnosis of ovarian cancer delayed by woeful lack of awareness
A global study of women with ovarian cancer has found that two thirds of women…
ESMO 2018: Olaparib maintenance extends PFS by estimated 3 years in advanced ovarian cancer
Two-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to…
Evidence mounts linking aspirin to lower risk of ovarian cancer
Taking a low-dose aspirin daily may help women lower their risk of developing ovarian cancer.…
Crosstalk between fallopian tube, ovary may drive the spread of ovarian cancer
New research from the University of Illinois at Chicago shows that cancer cells in the…
Discovery paves way for improved ovarian cancer care
Melbourne scientists have revealed a better way to identify which patients should respond to PARP…